Cra Intl Inc Stock Price, News & Analysis

Charles River Associates (NASDAQ: CRAI), a leading economic and management consulting firm, announced its participation in the Noble Capital Markets Emerging Growth Virtual Investor Conference. CEO Paul Maleh will present on October 8, 2025, at 9:00 a.m. ET.

The company's leadership team, including CFO Eric Nierenberg and Chief Corporate Development Officer Chad Holmes, will be available for investor meetings. An archived webcast of the presentation will be accessible through CRA's investor relations website.

Charles River Associates (NASDAQ: CRAI) has announced the appointment of Frances Hendry as Vice President in its Life Sciences Practice. Hendry brings significant experience in pharmaceutical consulting, specializing in product launches and portfolio optimization. Prior to joining CRA, she served as Vice President at a healthcare consulting firm and held senior roles at a U.K. marketing consultancy.

Hendry holds an MA in Business Management from Glasgow University, an MSC in Marketing from Edinburgh Napier University, and a CIM Postgraduate Diploma from Cambridge Marketing College. The appointment aligns with CRA's focus on strengthening client relationships and expanding its life sciences consulting capabilities.

Charles River Associates (NASDAQ: CRAI) has announced the appointment of Dr. Alison Hole as Vice President in their Antitrust & Competition Economics Practice. Dr. Hole brings over 20 years of experience in antitrust economics and joins CRA with significant expertise in merger analysis and antitrust investigations.

Dr. Hole's impressive background includes serving as Deputy Director for Antitrust at the FTC's Bureau of Economics for over 10 years, where she oversaw hundreds of investigations and contributed to the 2023 U.S. Merger Guidelines. She also previously held the position of Chief Economist at the U.K. Competition Commission and worked as an Executive Vice President at a global economic consulting firm.

Charles River Associates (NASDAQ: CRAI), a provider of economic, financial, and management consulting services, will participate in the upcoming Sidoti Small-Cap Virtual Conference on September 17-18, 2025. CEO Paul Maleh will present on September 17 at 10:00 a.m. ET, with the presentation available via webcast on CRA's investor relations website.

Additionally, CFO Eric Nierenberg and Chief Corporate Development Officer Chad Holmes will be available for virtual meetings with investors during the conference.

Charles River Associates (NASDAQ: CRAI) has strengthened its Forensic Services Practice with the appointment of Chris Rucinski as Vice President. Rucinski brings 15 years of experience in intellectual property and complex technology disputes, having testified as an expert in numerous high-profile cases and consulted on over 100 engagements.

The new VP, who holds a BA in Computer Science from Princeton University and is a GIAC Certified Forensic Examiner, specializes in analyzing complex software, source code, and hardware in contract, copyright, patent, and trade secret disputes. Prior to joining CRA, he served as Managing Director at a litigation consulting firm and Vice President at a technical services company.

Charles River Associates (NASDAQ: CRAI) has announced the appointment of Dr. Arin Mitra as Vice President in its Transfer Pricing Practice. Dr. Mitra brings over 30 years of experience from a Big Four firm, where he served as Lead Tax and Transfer Pricing Client Services Principal.

Dr. Mitra's expertise includes managing transfer pricing engagements, developing innovative software tools, and leading economic analysis for more than 50 bilateral Advanced Pricing Agreements involving multiple countries. His appointment strengthens CRA's capabilities in handling complex, cross-border tax issues for multinational clients.

Charles River Associates (NASDAQ: CRAI) has strengthened its Life Sciences Practice with the addition of two Vice Presidents, Phoebe Ng and Chris Nüesch. Ng brings 23 years of experience from a major pharmaceutical company, where she led new business development in global commercial strategy for various therapeutic areas. Nüesch joins with extensive consulting experience in life sciences, having served as a partner at a global management consulting firm.

The appointments align with CRA's data-driven approach and aim to enhance the company's ability to support clients in the evolving healthcare landscape. Both executives bring specialized expertise in portfolio strategy, product development, commercialization, and market access.

Charles River Associates (NASDAQ: CRAI) reported record-breaking financial results for Q2 2025, with revenue reaching $186.9 million, representing a 9.0% year-over-year growth. The company's net income surged 85.4% to $12.1 million, with earnings per diluted share increasing 90.4% to $1.79.

Seven practices showed growth, with Antitrust & Competition Economics, Energy, Intellectual Property, and Labor & Employment practices achieving double-digit revenue growth. Both North American (+9.4%) and international (+7.0%) operations contributed to this growth.

Based on strong performance, CRA raised its fiscal 2025 guidance, now expecting revenue between $730-745 million and non-GAAP EBITDA margin of 12.3-13.0%. The company also announced a quarterly dividend of $0.49 per share and returned $46.6 million to shareholders through dividends and share repurchases.

Charles River Associates (NASDAQ: CRAI), a leading economic and management consulting firm, has announced a quarterly cash dividend of $0.49 per common share. The dividend will be paid on September 12, 2025, to shareholders of record as of August 26, 2025.

While the company expects to continue its quarterly dividend payments, the declaration, timing, and amounts remain at the discretion of CRA's Board of Directors.